Osada N, Kikuchi J, Koyama D, Kuroda Y, Yasui H, Leverson JD, Furukawa Y. mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation. Haematologica 2021;106(11):3008-3013; https://doi.org/10.3324/haematol.2021.278506.